julia_l – Pagina 14 – Farmagens.it

Chi è julia_l

Questo autore non ha ancora scritto la sua biografia.
Ma siamo orgogliosi di dire che julia_l ha già contribuito con 243 voci.

Pubblicati da julia_l

The Golden Egg: Nutritional Value, Bioactivities, and Emerging Benefits for Human Health

8 Marzo 2021/in Pubblicazioni/da julia_l

Autore: Sophie Réhault-Godbert, Nicolas Guyot, Yves Nys. Biologie des Oiseaux et Aviculture, INRA, Université de Tours, Nouzilly, France.

Tear lactoferrin and lysozyme as clinically relevant biomarkers of mucosal immune competence

8 Marzo 2021/in Pubblicazioni/da julia_l

Autore: Helen G Hanstock, Jason P Edwards, Neil P Walsh Extremes Research Group, School of Sport, Health and Exercise Sciences, College of Health and Human Sciences, Bangor University, Bangor, United Kingdom, Swedish Winter Sports Research Centre, Department of Health Sciences, Mid Sweden University, Östersund, Sweden

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

8 Marzo 2021/in Pubblicazioni/da julia_l

Autore: Jenny Meinhardt, Josefine Radke, Carsten Dittmayer, Jonas Franz, Carolina Thomas, Ronja Mothes, Michael Laue, Julia Schneider, Sebastian Brünink, Selina Greuel, Malte Lehmann, Olga Hassan, Tom Aschman, Elisa Schumann, Robert Lorenz Chua, Christian Conrad, Roland Eils, Werner Stenzel, Marc Windgassen, Larissa Rößler, Hans-Hilmar Goebel, Hans R. Gelderblom, Hubert Martin, Andreas Nitsche, Walter J. Schulz-Schaeffer, Samy […]

Morphological Cell Profiling of SARS-CoV-2 Infection Identifies 1 Drug Repurposing Candidates for COVID-19

8 Marzo 2021/in Pubblicazioni/da julia_l

Autore: Carmen Mirabelli, Jesse W. Wotring, Charles J. Zhang, Sean M. McCarty, Reid Fursmidt, Tristan Frum, Namrata S. Kadambi, Anya T. Amin, Teresa R. O’Meara, Carla D. Pretto, Jason R. Spence, Jessie Huang, Konstantinos D. Alysandratos, Darrell N. Kotton, Samuel K. Handelman, Christiane E. Wobus, Kevin J. Weatherwax, George A. Mashour, Matthew J. O’Meara, and […]

Cardiology and COVID-19

8 Marzo 2021/in Pubblicazioni/da julia_l

Autore: Robert O. Bonow, Patrick T. O’Gara, Clyde W. Yancy.

Potential of large “first generation” human‐to‐human transmission of 2019‐nCoV

8 Marzo 2021/in Pubblicazioni/da julia_l

Autore: Xingguang Li Junjie Zai Xiaomei Wang Yi Li Hubei Engineering Research Center of Viral Vector, Wuhan University of Bioengineering, Wuhan, China. Immunology Innovation Team, School of Medicine, Ningbo University, Ningbo, China

SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19

8 Marzo 2021/in Pubblicazioni/da julia_l

Autore: Matteo Briguglio, Mauro Porta, Francesca Zuffada, Alberto R. Bona, Tiziano Crespi, Fabio Pino, Paolo Perazzo, Marco Mazzocchi, Riccardo Giorgino, Giuseppe De Angelis, Alfonso Ielasi, Giuseppe De Blasio and Maurizio Turiel

Dietary Lactoferrin Alleviates Age-Related Lacrimal Gland Dysfunction in Mice

8 Marzo 2021/in Pubblicazioni/da julia_l

Autore: Motoko Kawashima, Tetsuya Kawakita, Takaaki Inaba, Naoko Okada, Masataka Ito, Shigeto Shimmura, Mitsuhiro Watanabe, Ken Shinmura, Kazuo Tsubota Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan. Division of Geriatric Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. […]

Antioxidant effects of ovotransferrin and its hydrolysates

8 Marzo 2021/in Pubblicazioni/da julia_l

Autore: J. Kim, S. H. Moon, D. U. Ahn, H. D. Paik, E. Park Department of Food and Nutrition, Kyungnam University, Changwon 631−701, Korea; Division of Animal Life Science, Konkuk University, Seoul 143-701, Korea; Department of Animal Science, Iowa State University, Ames 50011

The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19

26 Gennaio 2021/in Pubblicazioni/da julia_l

Autore: Jaclyn Kelly Mann and Thumbi Ndungu

Chi è julia_l

Pubblicati da julia_l

The Golden Egg: Nutritional Value, Bioactivities, and Emerging Benefits for Human Health

Tear lactoferrin and lysozyme as clinically relevant biomarkers of mucosal immune competence

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19

Morphological Cell Profiling of SARS-CoV-2 Infection Identifies 1 Drug Repurposing Candidates for COVID-19

Cardiology and COVID-19

Potential of large “first generation” human‐to‐human transmission of 2019‐nCoV

SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19

Dietary Lactoferrin Alleviates Age-Related Lacrimal Gland Dysfunction in Mice

Antioxidant effects of ovotransferrin and its hydrolysates

The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19

About

Farmagens Health Care

Contatti